GlaxoSmithKline | GSK - Interest Income


GlaxoSmithKline reported GBP22M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
AbbVie USD 72M 13M Mar/2026
Almirall EUR 2.71M 580K Dec/2025
argenx SE USD 44M 874K Mar/2026
AstraZeneca USD 80M 7M Jun/2026
Bayer EUR 169M 39M Dec/2025
Biogen USD 37.9M 700K Mar/2026
Eli Lilly USD 65M 25M Sep/2025
Fresenius Medical Care EUR 14.7M 77K Jun/2026
Genmab DKK 14M 11M Mar/2026
Gilead Sciences USD 95M 0 Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
Glaxosmithkline GBP 22M 4M Mar/2026
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Merck EUR 36M 15M Mar/2026
Merck USD 35M 34M Mar/2026
Pfizer USD -0.04 115M Jun/2026
Philips EUR 33M 2M Jun/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sanofi EUR 77M 17M Jun/2026
Smith & Nephew USD 15M 6M Dec/2024